Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 7 (TA7)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06020755 |
|
Recruitment Status :
Not yet recruiting
First Posted : September 1, 2023
Last Update Posted : September 5, 2023
|
Sponsor:
Peking Union Medical College Hospital
Collaborators:
Obstetrics & Gynecology Hospital of Fudan University
Shengjing Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Henan Cancer Hospital
Gansu Provincial Maternal and Child Health Care Hospital
Dalian Maternity and Child Care Hospital
The First Affiliated Hospital of Xiamen University
Sichuan Cancer Hospital & Institute
Shanghai Junshi Bioscience Co., Ltd.
Information provided by (Responsible Party):
xiang yang, Peking Union Medical College Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | August 2025 |
| Estimated Study Completion Date : | August 2025 |